Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues
- 1 January 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 85, 646-657
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cholinesterase inhibitors from botanicalsPharmacognosy Reviews, 2013
- New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing PropertiesJournal of Medicinal Chemistry, 2012
- Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitorsBMC Bioinformatics, 2011
- Synthesis, biological activity and HPLC validation of 1,2,3,4-tetrahydroacridine derivatives as acetylcholinesterase inhibitorsEuropean Journal of Medicinal Chemistry, 2011
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Isosorbide-2-carbamate Esters: Potent and Selective Butyrylcholinesterase InhibitorsJournal of Medicinal Chemistry, 2008
- Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid AggregationJournal of Medicinal Chemistry, 2008
- Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Aβ1–42 aggregation for Alzheimer’s disease therapeuticsBioorganic & Medicinal Chemistry, 2007
- New Potent Acetylcholinesterase Inhibitors in the Tetracyclic Triterpene SeriesJournal of Medicinal Chemistry, 2007
- Trp82 and Tyr332 Are Involved in Two Quaternary Ammonium Binding Domains of Human Butyrylcholinesterase as Revealed by Photoaffinity Labeling with [3H]DDFBiochemistry, 1998